286 related articles for article (PubMed ID: 28850634)
1. Dynamics of hyperphenylalaninemia and intellectual outcome in teenagers with phenylketonuria.
Didycz B; Bik-Multanowski M
Acta Biochim Pol; 2017; 64(3):527-531. PubMed ID: 28850634
[TBL] [Abstract][Full Text] [Related]
2. Wechsler subscale IQ and subtest profile in early treated phenylketonuria.
Griffiths PV; Demellweek C; Fay N; Robinson PH; Davidson DC
Arch Dis Child; 2000 Mar; 82(3):209-15. PubMed ID: 10685922
[TBL] [Abstract][Full Text] [Related]
3. Neurocognitive functioning in adults with phenylketonuria: results of a long term study.
Weglage J; Fromm J; van Teeffelen-Heithoff A; Möller HE; Koletzko B; Marquardt T; Rutsch F; Feldmann R
Mol Genet Metab; 2013; 110 Suppl():S44-8. PubMed ID: 24071437
[TBL] [Abstract][Full Text] [Related]
4. Fluctuations in phenylalanine concentrations in phenylketonuria: a review of possible relationships with outcomes.
Cleary M; Trefz F; Muntau AC; Feillet F; van Spronsen FJ; Burlina A; Bélanger-Quintana A; Giżewska M; Gasteyger C; Bettiol E; Blau N; MacDonald A
Mol Genet Metab; 2013 Dec; 110(4):418-23. PubMed ID: 24090706
[TBL] [Abstract][Full Text] [Related]
5. Stability of blood phenylalanine levels and IQ in children with phenylketonuria.
Anastasoaie V; Kurzius L; Forbes P; Waisbren S
Mol Genet Metab; 2008; 95(1-2):17-20. PubMed ID: 18703366
[TBL] [Abstract][Full Text] [Related]
6. Relationships between phenylalanine levels, intelligence and socioeconomic status of patients with phenylketonuria.
Castro IP; Borges JM; Chagas HA; Tibúrcio J; Starling AL; Aguiar MJ
J Pediatr (Rio J); 2012 Jul; 88(4):353-6. PubMed ID: 22456753
[TBL] [Abstract][Full Text] [Related]
7. Intellectual development and academic achievement of children treated early for phenylketonuria.
Berry HK; O'Grady DJ; Perlmutter LJ; Bofinger MK
Dev Med Child Neurol; 1979 Jun; 21(3):311-20. PubMed ID: 467815
[TBL] [Abstract][Full Text] [Related]
8. Long-term follow-up of patients treated for phenylketonuria (PKU). Results from the Prague PKU Center.
Cechák P; Hejcmanová L; Rupp A
Eur J Pediatr; 1996 Jul; 155 Suppl 1():S59-63. PubMed ID: 8828612
[TBL] [Abstract][Full Text] [Related]
9. Predictors of intelligence quotient and intelligence quotient change in persons treated for phenylketonuria early in life.
Waisbren SE; Mahon BE; Schnell RR; Levy HL
Pediatrics; 1987 Mar; 79(3):351-5. PubMed ID: 3822635
[TBL] [Abstract][Full Text] [Related]
10. Quality of life and adherence to treatment in early-treated Brazilian phenylketonuria pediatric patients.
Vieira E; Maia HS; Monteiro CB; Carvalho LM; Tonon T; Vanz AP; Schwartz IVD; Ribeiro MG
Braz J Med Biol Res; 2017 Dec; 51(2):e6709. PubMed ID: 29267500
[TBL] [Abstract][Full Text] [Related]
11. Intellectual, neurologic, and neuropsychologic outcome in untreated subjects with nonphenylketonuria hyperphenylalaninemia. German Collaborative Study on Phenylketonuria.
Weglage J; Ullrich K; Pietsch M; Fünders B; Güttler F; Harms E
Pediatr Res; 1997 Sep; 42(3):378-84. PubMed ID: 9284280
[TBL] [Abstract][Full Text] [Related]
12. Neuropsychological assessment among children and adolescents with phenylketonuria and hyperphenylalaninemia and its relationship with plasma phenylalanine levels.
González García MB; Conde-Guzon P; Alcalde Martín C; Conde-Guzon MJ; Velasco Zúñiga R
Arch Argent Pediatr; 2017 Jun; 115(3):267-273. PubMed ID: 28504493
[TBL] [Abstract][Full Text] [Related]
13. Transitory hyperphenylalaninaemia in children with continuously treated phenylketonuria.
Griffiths P; Smith C; Harvie A
Am J Ment Retard; 1997 Jul; 102(1):27-36. PubMed ID: 9241405
[TBL] [Abstract][Full Text] [Related]
14. Loss of intellectual function in children with phenylketonuria after relaxation of dietary phenylalanine restriction.
Seashore MR; Friedman E; Novelly RA; Bapat V
Pediatrics; 1985 Feb; 75(2):226-32. PubMed ID: 3969322
[TBL] [Abstract][Full Text] [Related]
15. [Disease course in 20 patients with an early diagnosis of phenylketonuria and hyperphenylalaninemia].
Schwarz HP; Plüss C; Triaca H; Schütz B; Kaufmann R; Scherz R; Bachmann C; Zuppinger K
Schweiz Med Wochenschr; 1988 Jan; 118(3):94-9. PubMed ID: 3344414
[TBL] [Abstract][Full Text] [Related]
16. Variability in phenylalanine control predicts IQ and executive abilities in children with phenylketonuria.
Hood A; Grange DK; Christ SE; Steiner R; White DA
Mol Genet Metab; 2014 Apr; 111(4):445-51. PubMed ID: 24568837
[TBL] [Abstract][Full Text] [Related]
17. Final intelligence in late treated patients with phenylketonuria.
Trefz FK; Cipcic-Schmidt S; Koch R
Eur J Pediatr; 2000 Oct; 159 Suppl 2():S145-8. PubMed ID: 11043161
[TBL] [Abstract][Full Text] [Related]
18. Phenylketonuria and its variants: observations on intellectual functioning.
Netley C; Hanley WB; Rudner HL
Can Med Assoc J; 1984 Oct; 131(7):751-5. PubMed ID: 6478363
[TBL] [Abstract][Full Text] [Related]
19. Effect of stopping low-phenylalanine diet on intellectual progress of children with phenylketonuria.
Smith I; Lobascher ME; Stevenson JE; Wolff OH; Schmidt H; Grubel-Kaiser S; Bickel H
Br Med J; 1978 Sep; 2(6139):723-6. PubMed ID: 698696
[TBL] [Abstract][Full Text] [Related]
20. [Psychometry and psychological observations in early treated children with phenylketonuria (PKU) during 12 years (author's transl)].
Knoll E; Wehle E; Thalhammer O
Klin Padiatr; 1980 Nov; 192(6):599-607. PubMed ID: 7194401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
